Daiken Biomedical Co., Ltd. (7780.TWO)
- Previous Close
154.50 - Open
156.50 - Bid --
- Ask --
- Day's Range
154.00 - 160.00 - 52 Week Range
81.00 - 192.00 - Volume
54,512 - Avg. Volume
9,864 - Market Cap (intraday)
9.6B - Beta (5Y Monthly) --
- PE Ratio (TTM)
63.75 - EPS (TTM)
2.51 - Earnings Date --
- Forward Dividend & Yield 2.86 (1.85%)
- Ex-Dividend Date Feb 26, 2025
- 1y Target Est
--
Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd.
certifications.nutrasource.ca/certified-products/brand?id=DABI--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 7780.TWO
View MorePerformance Overview: 7780.TWO
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7780.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7780.TWO
View MoreValuation Measures
Market Cap
9.60B
Enterprise Value
8.41B
Trailing P/E
28.73
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.85
Price/Book (mrq)
7.89
Enterprise Value/Revenue
5.78
Enterprise Value/EBITDA
26.33
Financial Highlights
Profitability and Income Statement
Profit Margin
7.82%
Return on Assets (ttm)
8.15%
Return on Equity (ttm)
13.71%
Revenue (ttm)
1.36B
Net Income Avi to Common (ttm)
106.58M
Diluted EPS (ttm)
2.51
Balance Sheet and Cash Flow
Total Cash (mrq)
1.14B
Total Debt/Equity (mrq)
0.17%
Levered Free Cash Flow (ttm)
171.51M